Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
About this item
Full title
Author / Creator
Publisher
Brazil: Elsevier Editora Ltda
Journal title
Language
English
Formats
Publication information
Publisher
Brazil: Elsevier Editora Ltda
Subjects
More information
Scope and Contents
Contents
Chronic hepatitis B is a highly prevalent disease worldwide, leading to serious consequences if not properly treated. Six treatment options for chronic hepatitis B are currently provided by the Brazilian public health system. Telbivudine is a nucleoside analogue that is neither included in the Brazilian clinical protocol nor in the therapeutic guid...
Alternative Titles
Full title
Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b2c25ff056bf44c7a671aa64836fb4c5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b2c25ff056bf44c7a671aa64836fb4c5
Other Identifiers
ISSN
1413-8670
E-ISSN
1678-4391
DOI
10.1016/S1413-8670(11)70180-5
